Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
10 Mar 2026 Job Information Organisation/Company INSERM 1116 Research Field Medical sciences » Health sciences Biological sciences » Biology Pharmacological sciences » Clinical pharmacology
-
transferring complementary knowledge and technology, LipidBRIGHT aims to speed up innovations towards improved disease prevention, diagnosis, prognosis and therapy. LipidBRIGHT will train 11 scientists in a
-
» Biological engineering Researcher Profile First Stage Researcher (R1) Application Deadline 3 Apr 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer
-
» Biological engineering Researcher Profile Recognised Researcher (R2) Established Researcher (R3) Positions Postdoc Positions Application Deadline 25 Mar 2026 - 12:00 (Europe/Paris) Country France Type
-
complementary knowledge and technology, LipidBRIGHT aims to speed up innovations towards improved disease prevention, diagnosis, prognosis and therapy. LipidBRIGHT will train scientists in a close cooperation
-
MSCA Postdoctoral Fellowships @Sorbonne Université and its Alliance partners - Call for Applications
, Inserm, Inria, IRD, Muséum National d’Histoire Naturelle, Cnam and Université de Technologie de Compiègne). If you are a young research with high potential and ambition to advance research in fundamental
-
(45 rue des Saints Pères, 75006 Paris) was created on January 1, 2025, and brings together around 70 physicists, biologists, pharmacists, engineers, and doctors, including around 30 permanent staff
-
the research units of Sorbonne Université and its partners (CNRS, Inserm, Inria, IRD, Muséum national d’Histoire naturelle, Cnam and Université de technologie de Compiègne). If you are a young researcher with
-
26 Jan 2026 Job Information Organisation/Company CNRS Department NAnomédecine, Biologie extracellulaire, Intégratome et Innovations Research Field Pharmacological sciences Engineering Technology
-
Dr. Angela Taddei at Institut Curie (75005). The PEPR Cell-ID, under the scientific direction of Dr. Geneviève Almouzni, is funded by France 2030 and co-led by the CNRS and Inserm. Its objective is to